GB0602799D0 - Non-natural amino acid derivatives - Google Patents

Non-natural amino acid derivatives

Info

Publication number
GB0602799D0
GB0602799D0 GBGB0602799.9A GB0602799A GB0602799D0 GB 0602799 D0 GB0602799 D0 GB 0602799D0 GB 0602799 A GB0602799 A GB 0602799A GB 0602799 D0 GB0602799 D0 GB 0602799D0
Authority
GB
United Kingdom
Prior art keywords
amino acid
acid derivatives
natural amino
natural
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0602799.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Cambridge Ltd
Original Assignee
Proximagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proximagen Ltd filed Critical Proximagen Ltd
Priority to GBGB0602799.9A priority Critical patent/GB0602799D0/en
Publication of GB0602799D0 publication Critical patent/GB0602799D0/en
Priority to US12/278,422 priority patent/US20090036525A1/en
Priority to AU2007213550A priority patent/AU2007213550A1/en
Priority to CA002640470A priority patent/CA2640470A1/en
Priority to JP2008553815A priority patent/JP2009526027A/ja
Priority to EP07704982A priority patent/EP1981839A1/en
Priority to PCT/GB2007/000205 priority patent/WO2007091018A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0602799.9A 2006-02-11 2006-02-11 Non-natural amino acid derivatives Ceased GB0602799D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0602799.9A GB0602799D0 (en) 2006-02-11 2006-02-11 Non-natural amino acid derivatives
US12/278,422 US20090036525A1 (en) 2006-02-11 2007-01-23 Non-Natural Amino Acid Derivatives
AU2007213550A AU2007213550A1 (en) 2006-02-11 2007-01-23 Non-natural amino acid derivatives
CA002640470A CA2640470A1 (en) 2006-02-11 2007-01-23 Non-natural amino acid derivatives
JP2008553815A JP2009526027A (ja) 2006-02-11 2007-01-23 非−天然アミノ酸誘導体類
EP07704982A EP1981839A1 (en) 2006-02-11 2007-01-23 Non-natural amino acid derivatives
PCT/GB2007/000205 WO2007091018A1 (en) 2006-02-11 2007-01-23 Non-natural amino acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0602799.9A GB0602799D0 (en) 2006-02-11 2006-02-11 Non-natural amino acid derivatives

Publications (1)

Publication Number Publication Date
GB0602799D0 true GB0602799D0 (en) 2006-03-22

Family

ID=36119928

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0602799.9A Ceased GB0602799D0 (en) 2006-02-11 2006-02-11 Non-natural amino acid derivatives

Country Status (7)

Country Link
US (1) US20090036525A1 (https=)
EP (1) EP1981839A1 (https=)
JP (1) JP2009526027A (https=)
AU (1) AU2007213550A1 (https=)
CA (1) CA2640470A1 (https=)
GB (1) GB0602799D0 (https=)
WO (1) WO2007091018A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090286968A1 (en) 2008-04-25 2009-11-19 Auburn University 2-Quinoxalinol Salen Compounds and Uses Thereof
CN108495626A (zh) * 2015-09-02 2018-09-04 塞尔利克斯生物私人有限公司 用于治疗帕金森氏病的组合物和方法
JP7228828B2 (ja) * 2017-08-14 2023-02-27 学校法人神戸学院 ペプチド型細菌ジペプチジルペプチダーゼ７阻害剤
IL276555B1 (en) * 2018-02-08 2026-02-01 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Dopamine precursors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939253A (en) * 1973-11-02 1976-02-17 Interx Research Corporation Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease
US4065566A (en) * 1975-04-17 1977-12-27 Interx Research Corporation N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same
US5686423A (en) * 1996-02-16 1997-11-11 Department Of Health, The Executive Yuan, Republic Of China Di-and tri-peptide mimetic compounds for Parkinson's disease

Also Published As

Publication number Publication date
EP1981839A1 (en) 2008-10-22
US20090036525A1 (en) 2009-02-05
CA2640470A1 (en) 2007-08-16
JP2009526027A (ja) 2009-07-16
WO2007091018A1 (en) 2007-08-16
AU2007213550A1 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
EP2116238A4 (en) Amino acid composition
PL2164349T3 (pl) Bezproteinowa mieszanka dla niemowląt
IL197221A0 (en) Protein purification
IL197220A0 (en) Protein purification
EP2017283A4 (en) Peptides
GB0620934D0 (en) Protein variants
GB0611116D0 (en) Proteins
IL185790A0 (en) Amino acid derivatives
GB0713189D0 (en) Amino acid derivatives
ZA201102450B (en) Amino acid derivative
GB0715712D0 (en) Amino acid derivatives
EP2036918A4 (en) PEPTIDE DERIVATIVE
GB0601976D0 (en) Proteins
GB0624084D0 (en) Ramipril amino acid salts
GB0624227D0 (en) Protein purification
GB0602780D0 (en) Amino Acid Derivatives
GB0620735D0 (en) Proteins
GB0602799D0 (en) Non-natural amino acid derivatives
GB0610140D0 (en) Protein stability
GB0618748D0 (en) Peptide
IL197675A0 (en) Peptides
GB0605774D0 (en) Peptide
GB0612623D0 (en) Proteins
GB0612443D0 (en) Protein
EP2128136A4 (en) DERIVATIVE OF 2-PHENYLNICOTINIC ACID

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)